ESC Congress 2019 was an astonishing success: over 32,000 visitors and a programme spanning from Saturday August 31 to Wednesday September 4, focused on the best and latest science presented by renowned leaders in cardiovascular medicine. Being the largest such gathering in the world, ESC included more than 500 sessions during the five-day conference.
ESC is one of the professional events I cannot afford to miss, it is exciting to be part of a congress that covers so many interesting topics in cardiology. Everything is included – science, practice, exhibitions, interesting people. ESC is a unique opportunity to get connected with experts from all over the world and present original research. At the recent ESC Congress I had the opportunity to keep abreast of the latest news in cardiology and talk about my own research results with colleagues from many other countries: The congress definitely provided a stimulus for my future research and my clinical practice.
Now after such a great meeting I strongly suggest you review the ESC365 Congress resources: slides, videos and abstracts from ESC 2019.
Among the highlights was a satellite symposium held in 'The HUB Duras' on Monday September 2 (13:00 to 13:45) on ‘Inodilators in Acute and Advanced Heart Failure’, chaired by John T PARISSIS (Athens, Greece) and Francesco FEDELE (Roma, Italy).The symposium included presentations and discussions by Finn GUSTAFSSON (Copenhagen, Denmark), Veli-Pekka HARJOLA (Helsinki, Finland), yours truly Gerhard PÖLZL (Innsbruck, Austria), Josep COMIN-COLET (Hospitalet De Llobregat, Spain), Piergiuseppe AGOSTONI (Milan, Italy), and Carsten TSCHOEPE (Berlin, Germany).
The symposium discussed the LEODOR study (‘repetitive use of levosimendan in advanced heart failure patients’) protocol and there was also an investigator meeting to discuss the progress in initiation of the centers and enrollment of patients for this important study.